Target intelligence / Profile preview

Antigen-presenting cell machinery (APM)

Target
APM
Molecular classification
Other
01

Overview

The antigen-presenting cell (APC) machinery is a complex biological system responsible for the degradation of proteins into antigenic peptides and their subsequent presentation on the cell surface via Major Histocompatibility Complex (MHC) molecules (Rock et al., 2016). This process is essential for the adaptive immune system to monitor cellular health and detect foreign pathogens or mutated proteins. Key components of this machinery include the immunoproteasome, the Transporter associated with Antigen Processing (TAP), and various endoplasmic reticulum-resident chaperones like tapasin and calreticulin (Seliger, 2008). In oncology, tumors often downregulate components of this machinery to evade detection by cytotoxic T lymphocytes, making the restoration of APM function a significant area of therapeutic interest (Leone et al., 2013). Conversely, overactivity or inappropriate presentation of self-peptides can lead to autoimmune disorders where the immune system attacks healthy tissues (Neefjes et al., 2011). Drugs like proteasome inhibitors directly affect the processing stage, while cytokines like interferon-gamma can upregulate the entire pathway to enhance immunogenicity (Seliger, 2014).

Other names
Antigen processing and presentation machineryAPMMHC presentation pathwayAntigen processing pathway
02

Mechanism of action

Modulation of the proteasomal degradation of proteins, transport of peptides into the endoplasmic reticulum, and the assembly and surface expression of MHC-peptide complexes to alter T-cell recognition (Rock et al., 2016).

03

Biological functions

Immune responseAntigen processingAntigen presentationT-cell activation
04

Disease associations

CancerInfectionAutoimmune disease
05

Safety considerations

Risk of autoimmunityImmune evasion by tumorsSystemic inflammationCytokine release syndrome
06

Interacting drugs

Bortezomib

3 more in the full profile.

07

Biomarkers

MHC Class I expressionHLA-DR expressionTAP1 levelsTAP2 levelsBeta-2 microglobulin expression

Beyond the preview

Go deeper on Antigen-presenting cell machinery (APM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Antigen-presenting cell machinery (APM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call